Fairvalue-Calculator Fairvalue-Calculator
EN DE

Medicure Inc (MPH) Fair Value & Analysis

Healthcare · CA · Market cap C$11.2M

PriceC$1.25
Fair ValueC$0.8300
Upside-33.6%
Quality95/100
Evidence: Low Range C$0.6200 – C$1.24

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Medicure Inc (MPH) currently trades at C$1.25, while our model-based Fair Value estimate is C$0.8300 — implying the stock looks roughly 33.6% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing MC-1 for the treatment of PNPO deficiency; and TARDOXAL for neurological indications, such as Tardive Dyskinesia. It offers products through retail and mail order, and online pharmacies. The company was founded in 1997 and is headquartered in Winnipeg, Canada.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +3193% Jiangsu Hengrui Pharmaceuticals Co (600276) -37% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -1% Hansoh Pharmaceutical Group (3692) -37% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is Medicure Inc (MPH) undervalued?
As of Jun 25, 2026, our model estimates a fair value of C$0.8300 versus a price of C$1.25 — about −34% (overvalued). Model-based estimate, not financial advice.
What is the fair value of MPH?
Our 21-model fair value for Medicure Inc is C$0.8300 (as of Jun 25, 2026), built from audited fundamentals. The current price is C$1.25.
What is the quality score of MPH?
Medicure Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.